The caspase family of cell death proteases has been implicated in the mechanism of neuronal death following seizures. We investigated the expression and processing of caspases 6 and 7, putative executioner caspases. Brief limbic seizures were evoked by intraamygdala kainic acid to elicit unilateral death of target hippocampal CA3 neurons in the rat. Seizures rapidly induced cleavage of constitutively expressed caspase-6, followed by elevated VEIDase activity and the proteolysis of lamin A. Neuronal caspase-6 immunoreactivity was markedly upregulated within cortex and hippocampus in relation to bursts of polyspike paroxysmal discharges. In contrast, while caspase-7 expression also increased within cortical and hippocampal neuronal populations in response to the same seizure patterns, caspase-7 was not proteolytically activated. These data highlight differences in expression and activation of caspases 6 and 7 in response to identifiable seizure patterns, focusing potential therapeutic targets for neuroprotection in epilepsy.
INTRODUCTION
Cell death in a number of neurological diseases may progress via an inherently regulated pathway that has features consistent with apoptosis or programmed cell death (Nicholson, 1996; Savitz and Rosenbaum, 1998; Schulz et al., 1999) . Initiation and execution of such cell death pathways likely involves the caspase family of cell death proteases (Budihardjo et al., 1999; Earnshaw et al., 1999) and protective effects of caspase inhibitors have been demonstrated in a number of models of neurological disease (Hara et al., 1997; McBride et al., 1999; Schulz et al., 1999; Loetscher et al., 2001) . Initiation of the caspase cascade in the setting of neuronal injury likely occurs via either activation of surface-expressed death receptors linked to caspase-8/10 or release of mitochondrial apoptosis-activating factors leading to caspase-9 activation (Krajewski et al., 1999; Springer et al., 1999; Beer et al., 2000; Matsushita et al., 2000; Benchoua et al., 2001) . These pathways then converge on the three principal executioner/effector caspases 3, 6, and 7 that complete the cell death process (Budihardjo et al., 1999) . Caspase-3 is the best characterized of the executioner caspases and its activation has previously been shown in experimental and human stroke, traumatic brain injury and epilepsy (Chen et al., 1998; Namura et al., 1998; Clark et al., 1999; Henshall et al., 2000a,b) . In contrast, the role of caspases 6 and 7 in neuronal death resultant from brain injury remains little explored.
Caspase-6 (Mch2), expressed as a zymogen of ϳ35 kDa is capable of inducing apoptosis in multiple cell types (Fernandes-Alnemri et al., 1995; Faleiro et al., 1997; Herren et al., 1998) and can be activated by caspases 3, 7, 8, and 9 (Earnshaw et al., 1999; Van de Craen et al., 1999) . A number of substrates have been identified for caspase-6 including lamin A, poly (ADP ribose) polymerase (PARP) and caspases 2, 3 and 7 (Fernandes-Alnemri et al., 1995; Takahashi et al., 1996; Van de Craen et al., 1999; Allsopp et al., 2000) . A role
